Sterigenics International, a provider of contract sterilization, gamma technologies and medical isotopes, and a portfolio company of Warburg Pincus and GTCR, announced expansion at its Wiesbaden, Germany location. The expansion will increase ethylene oxide processing capacity by 20% and allow for additional future capacity expansion of an additional 20%. Construction will be completed by Q1 2017.
“This growth represents the continued execution of our development strategy,” said Michael Mulhern, CEO of Sterigenics International. “We will continue to pursue high impact acquisitions such as the recent addition of Nelson Laboratories, while at the same time, expanding our existing capabilities.”
Opened in 2006, Sterigenics International in Wiesbaden provides routine ethylene oxide processing, rapid turnaround STAT service, process validation and laboratory testing.